Safety and pharmacokinetic comparison between fenofibric acid 135 mg capsule and 110 mg enteric-coated tablet in healthy volunteers

This study aimed to compare the pharmacokinetic (PK) and safety profiles of 2 fenofibric acid formulations under fasting and fed conditions. The reference was a 135 mg capsule, while the test was a 110 mg enteric-coated tablet. This randomized, open-label, two-sequence, two-period crossover phase 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Yu-Bin, Kim, Jae Hoon, Song, Ji Hye, Jung, WonTae, Nam, Kyu-Yeol, Kim, Nyung, Choi, Youn-Woong, Cho, SangMin, Ki, Do-Hyung, Lee, Hye Jung, Moon, JungHa, Lee, SeungSeob, Kim, JaeHee, Hong, Jang Hee, Sunwoo, Jung, Jung, Jin-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333648/
https://www.ncbi.nlm.nih.gov/pubmed/37440778
http://dx.doi.org/10.12793/tcp.2023.31.e7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333648/
https://www.ncbi.nlm.nih.gov/pubmed/37440778
http://dx.doi.org/10.12793/tcp.2023.31.e7

Ejemplares similares